A University of Kentucky scientist has found two markers that can be collected through a cheek swab and indicate the presence ...

A gene mutation linked to schizophrenia may cause the brain to cling to outdated beliefs by disrupting a key decision-making ...

A newly identified gene mutation may help explain why schizophrenia patients struggle to update their understanding of ...

Eliminating outreach to people with severe mental illness set off such a cascade of bad outcomes that Idaho has scrambled to ...

Alto Neurosciences is halting work on its schizophrenia prospect after the brain-penetrant drug flunked a phase 2 study. The Bay Area biotech evaluated 10 days of treatment with t ...

Schizophrenia is a severe mental disorder affecting about 1% of the population worldwide, and is notoriously difficult to ...

Currently available antipsychotic drugs can help to control a patient's hallucinations and delusions but they don't improve ...

For decades, scientists have suspected that the voices heard by people with schizophrenia might be their own inner speech gone awry. Now, researchers have found brainwave evidence showing exactly how ...

The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of drug for the condition in more than 30 years. In contrast to antipsychotics ...

Boehringer Ingelheim and Click Therapeutics are restructuring their marketing deal for the software-based schizophrenia ...

A novel drug, evenamide, quieted overactive brain circuits in an animal model of schizophrenia, improving memory, social interaction, and dopamine balance, offering hope for tackling symptoms that ...

For decades, scientists studying brain disorders have focused almost exclusively on proteins and the genes encoding them. Now ...